Uyanikoglu, A. Et Al. 2014. Infliximab in inflammatory bowel disease: attention to adverse events. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.18, no.16 , 2337-2342.

Uyanikoglu, A., Ermis, F., Akyuz, F., Pinarbasi, B., Baran, B., Aydogan, T., ... Demir, K.(2014). Infliximab in inflammatory bowel disease: attention to adverse events. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.18, no.16, 2337-2342.

Uyanikoglu, A. Et Al. "Infliximab in inflammatory bowel disease: attention to adverse events," EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.18, no.16, 2337-2342, 2014

Uyanikoglu, A. Et Al. "Infliximab in inflammatory bowel disease: attention to adverse events." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.18, no.16, pp.2337-2342, 2014

Uyanikoglu, A. Et Al. (2014) . "Infliximab in inflammatory bowel disease: attention to adverse events." EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES , vol.18, no.16, pp.2337-2342.

@article{article, author={A. Uyanikoglu Et Al. }, title={Infliximab in inflammatory bowel disease: attention to adverse events}, journal={EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES}, year=2014, pages={2337-2342} }